High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023–2024
Authors:
- Jolein Gyonne Elise LaumenJLJolein Gyonne Elise Laumen
- Vu N HieuVHVu N Hieu
- Pham H NhungPNPham H Nhung
- Koen VandelannooteKVKoen Vandelannoote
- Nguyen Thi TamNTNguyen Thi Tam
- Nguyen T TrangNTNguyen T Trang
- Nguyen T N DiepNDNguyen T N Diep
- Thomas KestemanTKThomas Kesteman
- Rogier H van DoornRDRogier H van Doorn
- Paul C AdamsonPAPaul C Adamson
Open Access
- 12 February 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (1) , e73-e77
Abstract
Ceftriaxone resistance in Neisseria gonorrhoeae is an escalating global health concern, threatening the efficacy of empiric treatment. In the Asia-Pacific region, a rapid surge in ceftriaxone resistance has been observed, primarily associated with the penA-60.001 allele. This study, conducted in Hanoi, Vietnam between 2023 and 2024, analyzed 352 N. gonorrhoeae isolates and found a 27% prevalence of ceftriaxone resistance. Whole-genome sequencing identified that resistance was predominantly driven by the mosaic penA-237.001 allele, with a smaller contribution from penA-60.001. The high prevalence of resistance and the emergence of new alleles underscore the urgent threat to ceftriaxone as an empiric treatment option.Keywords
Funding Information
- National Institutes of Health
- Fogarty International Center (K01TW012170)
This publication has 13 references indexed in Scilit:
- Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet NamThe Lancet Infectious Diseases, 2024
- Ceftriaxone-Resistant Gonorrhea — China, 2022MMWR. Morbidity and Mortality Weekly Report, 2024
- Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USAThe Lancet Infectious Diseases, 2024
- Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023Eurosurveillance, 2023
- Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022Eurosurveillance, 2022
- Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022Eurosurveillance, 2022
- Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017–2019BMC Infectious Diseases, 2020
- Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–16Journal of Antimicrobial Chemotherapy, 2020
- A real-time PCR assay for detecting a penA mutation associated with ceftriaxone resistance in Neisseria gonorrhoeaeJournal of Global Antimicrobial Resistance, 2019
- Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae StrainEmerging Infectious Diseases, 2018